Rockwell Medical, Inc.2024财年第二财季实现净利润285000.00美元，同比增加108.61%

自选股智能写手08-18

8月18日，Rockwell Medical, Inc.（RMTI.US）公布财报，公告显示公司2024财年第二财季净利润为285000.00美元，同比增加108.61%；其中营业收入为25.83百万美元，同比增加42.87%，每股基本收益为0.01美元。从资产负债表来看，Rockwell Medical, Inc.（RMTI.US）总负债29.53百万美元，其中短期债务2.70百万美元，资产负债...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2460361127?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-08-18 00:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2460361127","market":"us","top_or_hot":-1,"title":"Rockwell Medical, Inc.2024财年第二财季实现净利润285000.00美元，同比增加108.61%","media":"自选股智能写手","content":"<div>\n<p>8月18日，Rockwell Medical, Inc.（RMTI.US）公布财报，公告显示公司2024财年第二财季净利润为285000.00美元，同比增加108.61%；其中营业收入为25.83百万美元，同比增加42.87%，每股基本收益为0.01美元。从资产负债表来看，Rockwell Medical, Inc.（RMTI.US）总负债29.53百万美元，其中短期债务2.70百万美元，资产负债...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800002695a162cb&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rockwell Medical, Inc.2024财年第二财季实现净利润285000.00美元，同比增加108.61%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRockwell Medical, Inc.2024财年第二财季实现净利润285000.00美元，同比增加108.61%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-08-18 00:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800002695a162cb&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>8月18日，Rockwell Medical, Inc.（RMTI.US）公布财报，公告显示公司2024财年第二财季净利润为285000.00美元，同比增加108.61%；其中营业收入为25.83百万美元，同比增加42.87%，每股基本收益为0.01美元。从资产负债表来看，Rockwell Medical, Inc.（RMTI.US）总负债29.53百万美元，其中短期债务2.70百万美元，资产负债...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800002695a162cb&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RMTI","symbol_name":"Rockwell Medical","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800002695a162cb&s=b","article_id":"2460361127","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081800002695a162cb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2460361127","pubTimestamp":1723910412,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"8月18日，Rockwell Medical, Inc.公布财报，公告显示公司2024财年第二财季净利润为285000.00美元，同比增加108.61%；其中营业收入为25.83百万美元，同比增加42.87%，每股基本收益为0.01美元。从资产负债表来看，Rockwell Medical, Inc.总负债29.53百万美元，其中短期债务2.70百万美元，资产负债比为1.80，流动比率为2.00。机构评级：截至2024年8月18日，当前有2家机构对Rockwell Medical, Inc.目标价做出预测，其中目标均价为7.50美元，其中最低目标价为6.00美元，最高目标价为9.00美元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":["earning"],"viewcount":null,"language":"zh","relate_stocks":{"RMTI":"Rockwell Medical"},"translate_title":"Rockwell Medical, Inc. achieved a net profit of US $285,000.00 in the second fiscal quarter of fiscal year 2024, a year-on-year increase of 108.61%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RMTI":1},"content_text":"8月18日，Rockwell Medical, Inc.（RMTI.US）公布财报，公告显示公司2024财年第二财季净利润为285000.00美元，同比增加108.61%；其中营业收入为25.83百万美元，同比增加42.87%，每股基本收益为0.01美元。从资产负债表来看，Rockwell Medical, Inc.（RMTI.US）总负债29.53百万美元，其中短期债务2.70百万美元，资产负债比为1.80，流动比率为2.00。机构评级：截至2024年8月18日，当前有2家机构对Rockwell Medical, Inc.目标价做出预测，其中目标均价为7.50美元，其中最低目标价为6.00美元，最高目标价为9.00美元。公司简介：罗克韦尔医药有限公司是一家医疗保健公司，为透析提供商开发、制造、商业化和分销一系列血液透析产品。该公司为美国的透析患者提供液体碳酸氢盐浓缩物以及酸性和干燥碳酸氢盐浓缩物。 该公司的产品包括 CitraPure 浓缩柠檬酸、RenalPure 液体浓缩酸和 SteriLyte 浓缩碳酸氢盐等。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.26.2","shortVersion":"4.26.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2460361127"}